Stephanie Kaypee

[Shreyas Sridhar, Ph.D. @ShreS360]

Excited to share my PhD work in @NatureComms involving the discovery of "Bridgin" and insights into it's evolutionary implications and role at the kinetochore! Thanks for the support @KaustuvSanyal and @tatsuofukagawa1 for a rewarding collaboration
https://t.co/QSJGXmT4eh

[Biopatrika @biopatrika]

#authorinterview @ShreS360 MS-PhD from lab of @KaustuvSanyal @jncasr talks about his work on Understanding fundamental design principles of a cellular load-bearing machine and recent article on bridgin published in @NatureComms. @tatsuofukagawa1
@IndiaDST
https://t.co/Dqk4XgRj5x

[Nature Portfolio @NaturePortfolio]

By the time a person notices the first symptoms of cancer, the disease has often spread too far to be treated successfully. That could change, thanks to a blood test that can detect more than 50 types of cancer, often at an early stage. #ResearchHighlight https://t.co/4L8ioVZdtk

[Nature Portfolio @NaturePortfolio]

More than 90 vaccines are being developed against SARS-CoV-2 across the world. At least six groups have begun injecting formulations into volunteers in safety trials. Here is a graphical guide explaining each vaccine design. #COVID19 https://t.co/7Mv1pmbmlg

[Nature Portfolio @NaturePortfolio]

A study in Nature found 42.5% of the confirmed SARS-CoV-2 infections in Vo', Italy, were asymptomatic. The study also finds no statistically significant difference in the viral load of symptomatic versus asymptomatic infections. #COVID19 https://t.co/iB35ahGYz0

[iScience journal @iScience_CP]

Mutant and Wild type Tumor Suppressor p53 induces p300 Autoacetylation https://t.co/6WAmWxgw9W

[Stephanie Kaypee @KaypeeStephanie]

Check out our work on wild type and mutant p53 in the regulation of p300 acetyltransferase activity. #epigenetic #chromatin #p53 #p300 https://t.co/cNvCvBRs6J